Stenvinkel P (Division of Renal Medicine, Department of Clinical Science, Intervention and
Technology, Karolinska Institutet, Stockholm, Sweden). Chronic kidney disease: a public …

The first reports connecting uremic inflammation with a wasted and atherogenic phenotype
and poor outcome initiated in the late 1990s. Since then, about 3500 publications appear on …

Objective To better define the prevalence of protein-energy wasting (PEW) in kidney disease
is poorly defined. Methods We performed a meta-analysis of PEW prevalence from …

Background: Serum albumin (S-Alb), C-reactive protein (CRP), and interleukin 6 (IL-6)
predict malnutrition, atherosclerotic cardiovascular disease (CVD), and mortality in patients …

Peritonitis is a well-known cause of mortality in peritoneal dialysis (PD) patients. We carried
out a retrospective study to disclose the clinical spectrum and risk profile of peritonitis …

Abstract Background. Fetuin-A (α2-Heremans Schmid glycoprotein) has recently been
identified as a circulating inhibitor of calcification and is regulated as a negative acute phase …

Preserving residual renal function has always been the primary clinical goal for every
nephrologist managing patients with chronic kidney disease. There is no reason why this …

C-reactive protein (CRP), the prototype marker of inflammation, and cardiac hypertrophy are
important prognostic indicators in dialysis patients. Residual renal function (RRF) has also …

Cardiovascular disease contributes significantly to the adverse clinical outcomes of
peritoneal dialysis (PD) patients. Numerous cardiovascular risk factors play important roles …

Mortality is markedly elevated in hemodialysis (HD) patients. Between 30 and 50% of
prevalent patients have elevated serum levels of inflammatory markers such as C-reactive …